- Home
- HYFT vs SEER Comparison
HYFT vs SEER Comparison
Compare HYFT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | SEER |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4M | 98.2M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HYFT | SEER |
|---|---|---|
| Price | $2.28 | $1.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 666.7K | 151.7K |
| Earning Date | 12-15-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,019,110.00 | $16,376,999.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | $51.71 | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.46 | 12.11 |
| 52 Week Low | $0.27 | $1.62 |
| 52 Week High | $3.25 | $2.44 |
Technical Indicators
Market Signals| Indicator | HYFT | SEER |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.75 |
| Support Level | N/A | $1.84 |
| Resistance Level | N/A | $1.92 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 54.32 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.